Nuveen Dow 30SM Dynamic Overwrite Fund Common Stock

The latest common stock for DIAX is $360K as of December 2025. That compares with $360K in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Nuveen Dow 30SM Dynamic Overwrite Fund's historical trend and sector peers before judging valuation or financial health.

Over the past year, DIAX's common stock moved from $360K to $360K — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nuveen Dow 30SM Dynamic Overwrite Fund's operating scale or balance-sheet position.

A common stock figure of $360K for DIAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DIAX's common stock ($360K), review year-over-year change from $360K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.